Pernix Therapeutics Debt to Equity Ratio:
0.5556 for Dec. 31, 2012Pernix Therapeutics Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.5556 |
| Sept. 30, 2012 | 0.0215 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.1085 |
| Dec. 31, 2011 | 0.1209 |
| Sept. 30, 2011 | 0.1368 |
| June 30, 2011 | 0.2745 |
| March 31, 2011 | 0.2986 |
| Dec. 31, 2010 | 0.2645 |
| Sept. 30, 2010 | 0.1265 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| Dec. 31, 2009 | 0.00 |
| Sept. 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.462 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
PTX Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Supernus Pharmaceuticals | 0.3977 |
| MEI Pharma | 0.00 |
| Apricus Biosciences | 0.5155 |
PTX Debt to Equity Ratio Rankings
| Overall |
58th percentile 3128 of 7590 |
| Sector |
35th percentile 421 of 651 in Healthcare |
| Industry |
32nd percentile 44 of 65 in Drug Manufacturers - Specialty & Generic |
PTX Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.00 | Sep 2008 |
| Maximum | 0.5556 | Dec 2012 |
| Average | 0.1247 |
